by William Jester | Jun 2, 2020 | Community, Covid, News
Imagine being told to inhale a nasal spray full of the coronavirus. More than 14,000 people in the U.S. and elsewhere are putting their names forward to do so. They are volunteering for what’s called a “human challenge trial,” an ethically...
by William Jester | Jun 1, 2020 | Community, Covid
Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning...
by Pamela Dahlen | Jun 1, 2020 | Community, Covid, News
A team of environmental engineers at NJIT is developing a new way to track the spread of SARS-CoV-2, the novel coronavirus, by combining advanced statistical methods with models that incorporate environmental conditions, such as wind speed, temperature and social...
by William Jester | May 30, 2020 | Community, Covid, News
Now that the Food and Drug Administration has authorized remdesivir for emergency use in seriously ill COVID-19 patients, the experimental drug is another step closer to full approval. That’s when most drugs get price tags. Gilead Sciences, which makes...
by William Jester | May 30, 2020 | Community, Covid, News
Rutgers has launched a clinical trial to test the safety and efficacy of an oral anti-inflammatory drug that could help prevent serious illness and death in early-stage COVID-19 patients. The drug, EDP1815, developed by Evelo Biosciences Inc., will be given to newly...
